title: Judicious use of antenatal glucocorticoids: putting the risks into the balance.
abstract: The administration of a course of antenatal glucocorticoids (AG) to improve neonatal outcome after preterm birth is a prime example of evidence-based medicine, but the current clinical application of AG is too broad. AG override the glucocorticoid enzymatic placental barrier in order to elicit fetal lung maturation at a pre-physiological gestational age. Yet the maturation benefit is accompanied by a number of undesirable phenomena, most of which are transient (lasting for at least 24-48 h after the last injection). These include metabolic effects in both mother and fetus and signs of reduced fetal wellbeing. In addition, the fetal growth rate slows down depending on the number of AG courses. Multiple courses may increase the risk of cerebral palsy, as neonatal dexamethasone treatment does. There are no randomised trials on the benefit-risk balance of AG in pregnancies complicated by diabetes or intra-uterine growth restriction (IUGR). Animal studies indicate that AG are associated with an inadequate response to acute hypoxaemia and different brain development. Judicious use of AG includes avoidance of multiple courses, and a case-based -approach in pregnancies with (pre)gestational diabetes, IUGR or equivocal fetal condition, until more data become available. In addition, better prediction models of preterm birth are needed.
authors.affiliation: Department of Obstetrics and Gynaecology, U.Z. Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Verhaeghe
keywords: antenatal glucocorticoids; fetal growth; fetal wellbeing; hyperglycaemia
references.citation: Neonatology. 2010;98(3):217-24
references.pmid: 20389126
references.citation: Pediatr Res. 2007 Jan;61(1):111-6
references.pmid: 17211151
references.citation: Mol Endocrinol. 2011 Aug;25(8):1280-8
references.pmid: 21659474
references.citation: J Physiol. 2005 Sep 1;567(Pt 2):673-88
references.pmid: 15975982
references.citation: Early Hum Dev. 2009 Dec;85(12):767-71
references.pmid: 19926412
references.citation: Am J Obstet Gynecol. 1998 May;178(5):1035-40
references.pmid: 9609580
references.citation: Early Hum Dev. 2010 May;86(5):319-25
references.pmid: 20547444
references.citation: Fetal Diagn Ther. 2005 Sep-Oct;20(5):371-6
references.pmid: 16113556
references.citation: Am J Obstet Gynecol. 2008 Oct;199(4):380.e1-4
references.pmid: 18928980
references.citation: Semin Fetal Neonatal Med. 2009 Apr;14(2):111-8
references.pmid: 19249005
references.citation: Acta Obstet Gynecol Scand. 2011 Jul;90(7):719-27
references.pmid: 21426310
references.citation: Am J Obstet Gynecol. 2008 Jan;198(1):105.e1-9
references.pmid: 17880903
references.citation: Am J Obstet Gynecol. 1982 Oct 1;144(3):276-82
references.pmid: 7124842
references.citation: J Perinat Med. 1996;24(3):243-51
references.pmid: 8827573
references.citation: BMJ. 2011 Apr 12;342:d1696
references.pmid: 21487057
references.citation: J Clin Endocrinol Metab. 1995 Nov;80(11):3127-30
references.pmid: 7593413
references.citation: Endocr Rev. 2011 Jun;32(3):317-55
references.pmid: 21051591
references.citation: Endocrinology. 2008 Dec;149(12):6343-55
references.pmid: 18755792
references.citation: BMJ. 2007 Jul 14;335(7610):77-9
references.pmid: 17626962
references.citation: N Engl J Med. 2007 Sep 20;357(12):1190-8
references.pmid: 17881751
references.citation: Obstet Gynecol. 2007 Jul;110(1):26-30
references.pmid: 17601892
references.citation: Am J Obstet Gynecol. 2010 Feb;202(2):166.e1-6
references.pmid: 20022312
references.citation: Early Hum Dev. 2009 Apr;85(4):253-7
references.pmid: 19028421
references.citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3449-53
references.pmid: 15741252
references.citation: J Clin Invest. 2007 Apr;117(4):1058-67
references.pmid: 17380204
references.citation: Endocrinology. 2007 Mar;148(3):1288-95
references.pmid: 17158204
references.citation: Metabolism. 2011 Jan;60(1):71-7
references.pmid: 20537667
references.citation: Pediatr Res. 2007 Sep;62(3):295-300
references.pmid: 17622956
references.citation: J Clin Endocrinol Metab. 1994 Oct;79(4):1063-9
references.pmid: 7962275
references.citation: BMJ. 2002 Aug 10;325(7359):301
references.pmid: 12169504
references.citation: J Bone Miner Res. 2010 Apr;25(4):920-7
references.pmid: 20437610
references.citation: Obstet Gynecol. 1997 Dec;90(6):880-3
references.pmid: 9397094
references.citation: Endocrinology. 2011 Sep;152(9):3561-70
references.pmid: 21733830
references.citation: Diabetes Care. 2004 Dec;27(12):2824-8
references.pmid: 15562192
references.citation: Am J Obstet Gynecol. 2006 Sep;195(3):633-42
references.pmid: 16846587
references.citation: Br J Obstet Gynaecol. 1997 Nov;104(11):1233-8
references.pmid: 9386022
references.citation: Neurosci Biobehav Rev. 2010 Sep;35(1):17-22
references.pmid: 19914282
references.citation: Pediatr Res. 2005 Apr;57(4):545-9
references.pmid: 15695600
references.citation: Pediatrics. 2007 Feb;119(2):290-8
references.pmid: 17272618
references.citation: Pediatrics. 2008 Oct;122(4):775-81
references.pmid: 18829801
references.citation: J Clin Invest. 2009 Feb;119(2):243-6
references.pmid: 19244604
references.citation: Pediatr Res. 2005 May;57(5 Pt 1):662-6
references.pmid: 15774821
references.citation: Am J Obstet Gynecol. 1999 May;180(5):1283-8
references.pmid: 10329891
references.citation: Lancet. 2008 Dec 20;372(9656):2143-51
references.pmid: 19101390
references.citation: J Clin Endocrinol Metab. 2001 Jan;86(1):104-9
references.pmid: 11231985
references.citation: Br J Obstet Gynaecol. 1997 Nov;104(11):1239-47
references.pmid: 9386023
references.citation: Obstet Gynecol. 2009 Mar;113(3):636-640
references.pmid: 19300328
references.citation: Biol Neonate. 1993;64(5):318-24
references.pmid: 8297942
references.citation: Am J Obstet Gynecol. 2010 Sep;203(3):254.e1-12
references.pmid: 20816148
references.citation: Diabetes Care. 2011 Aug;34(8):1683-8
references.pmid: 21636798
references.citation: N Engl J Med. 2007 Sep 20;357(12):1179-89
references.pmid: 17881750